In short
Ferumoxytol, also known by the brand name Feraheme, is an intravenous iron replacement product originally approved for treating iron deficiency anemia in patients with chronic kidney disease. However, recent clinical trials are exploring its potential in various other medical applications, particularly as a contrast agent for magnetic resonance imaging (MRI). This article summarizes key findings from several clinical trials investigating novel uses of ferumoxytol beyond its primary indication.
What is Ferumoxytol?
Ferumoxytol is a medication primarily used to treat iron deficiency anemia in patients with chronic kidney disease. It's also known by its brand name Feraheme. Ferumoxytol is classified as an iron replacement product and belongs to a group of medications called ultrasmall superparamagnetic iron oxide (USPIO) particles.
Other names for ferumoxytol include: FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE Feraheme These alternative names may be used interchangeably in medical literature or by healthcare providers.
Uses of Ferumoxytol
Ferumoxytol is primarily used for: Treatment of Iron Deficiency Anemia: It's approved for treating iron deficiency anemia in patients with chronic kidney disease. Anemia is a condition where you don't have enough healthy red blood cells to carry adequate oxygen to your body's tissues, often caused by iron deficiency. As a Contrast Agent in Medical Imaging: Ferumoxytol is being studied as an alternative contrast agent for magnetic resonance imaging (MRI) in patients who cannot receive standard gadolinium-based contrast agents. This is particularly useful for patients with kidney problems who are at risk of complications from gadolinium-based agents.
How Ferumoxytol Works
Ferumoxytol works in two main ways: As an Iron Replacement: When used to treat anemia, ferumoxytol provides iron to the body. Iron is essential for the production of hemoglobin, the protein in red blood cells that carries oxygen. As an Imaging Agent: When used in MRI, the iron particles in ferumoxytol affect the magnetic properties of tissues, allowing for enhanced visualization of blood vessels and certain types of cells. This is particularly useful for imaging inflammation and blood flow in various conditions.
Administration and Dosage
Ferumoxytol is typically administered intravenously (through a vein). The dosage and administration schedule can vary depending on the specific use: For anemia treatment, a common dosage is two 510 mg injections given 3-8 days apart. When used as an imaging agent, the dose is usually based on body weight, often around 4-5 mg of iron per kilogram of body weight. Always follow your healthcare provider's instructions regarding dosage and administration.
Ferumoxytol in Medical Imaging
Ferumoxytol is being studied extensively for its potential in various imaging applications: Brain Imaging: It's being investigated for visualizing inflammation in brain tumors and other neurological conditions. Vascular Imaging: Ferumoxytol can help visualize blood vessels, which is useful in diagnosing conditions like peripheral artery disease. Cardiac Imaging: Studies are exploring its use in visualizing coronary arteries, potentially offering an alternative for patients who can't receive standard contrast agents. These applications are still being researched and are not yet standard practice.
Safety and Side Effects
While ferumoxytol is generally considered safe, it can cause side effects. Common side effects may include: Dizziness Headache Nausea Constipation In rare cases, more serious allergic reactions can occur. Your healthcare provider will monitor you closely during and after administration.
Ongoing Research
Ferumoxytol is the subject of ongoing research in various areas: Pediatric Use: Studies are investigating its safety and efficacy in children with chronic kidney disease and iron deficiency anemia. Neurological Conditions: Research is exploring its potential in imaging brain inflammation in conditions like HIV-associated cognitive disorders. Cardiovascular Imaging: Studies are assessing its use in visualizing coronary arteries, particularly in patients with kidney problems. These studies aim to expand our understanding of ferumoxytol's potential uses and benefits in various medical fields.